Researchers have developed a molecular compound that reversed the symptoms of Alzheimer’s in mice. The compound also reduced inflammation of the brain.
The compound, antisense oligonucleotide (OL-1), “reversed learning and memory deficits and brain inflammation in mice that are genetically engineered to model Alzheimer’s disease,” said Susan Farr, Ph.D., research professor of geriatrics at Saint Louis University.
The findings were published in the Journal of Alzheimer’s Disease.